Jason Wittes
Stock Analyst at Roth Capital
(3.46)
# 948
Out of 5,005 analysts
63
Total ratings
49.09%
Success rate
6.27%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SPRY ARS Pharmaceuticals | Initiates: Buy | $40 | $10.27 | +289.48% | 1 | Sep 4, 2025 | |
| SYK Stryker | Maintains: Buy | $405 → $456 | $366.28 | +24.49% | 11 | May 2, 2025 | |
| ALUR Allurion Technologies | Reiterates: Buy | $16 | $2.07 | +674.82% | 2 | Mar 21, 2025 | |
| MGRM Monogram Technologies | Maintains: Buy | $4 → $5.4 | $6.00 | -10.00% | 2 | Mar 18, 2025 | |
| FBIO Fortress Biotech | Reiterates: Buy | $15 → $16 | $3.11 | +414.47% | 3 | Mar 11, 2025 | |
| OFIX Orthofix Medical | Reiterates: Buy | $22 | $14.31 | +53.79% | 5 | Feb 26, 2025 | |
| IRMD IRADIMED CORPORATION | Reiterates: Buy | $60 → $72 | $71.76 | +0.33% | 3 | Feb 14, 2025 | |
| TLSI TriSalus Life Sciences | Reiterates: Buy | $11 | $4.59 | +139.65% | 2 | Jan 24, 2025 | |
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $60.17 | +91.13% | 4 | Dec 17, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $12.22 | +194.60% | 1 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $11 | $7.29 | +50.89% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.08 | +825.93% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $100 | $87.49 | +14.30% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $3.30 | +51.52% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $1.71 | +426.32% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $31.26 | +139.92% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $13.62 | +61.53% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $98.83 | +21.42% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $148.14 | +39.06% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $193.27 | -24.98% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $15.23 | -1.51% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $14.50 | +1,279.31% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $36.76 | -29.27% | 1 | Feb 22, 2017 |
ARS Pharmaceuticals
Sep 4, 2025
Initiates: Buy
Price Target: $40
Current: $10.27
Upside: +289.48%
Stryker
May 2, 2025
Maintains: Buy
Price Target: $405 → $456
Current: $366.28
Upside: +24.49%
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $2.07
Upside: +674.82%
Monogram Technologies
Mar 18, 2025
Maintains: Buy
Price Target: $4 → $5.4
Current: $6.00
Upside: -10.00%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15 → $16
Current: $3.11
Upside: +414.47%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $14.31
Upside: +53.79%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60 → $72
Current: $71.76
Upside: +0.33%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $4.59
Upside: +139.65%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $60.17
Upside: +91.13%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $12.22
Upside: +194.60%
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $7.29
Upside: +50.89%
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.08
Upside: +825.93%
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $87.49
Upside: +14.30%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $3.30
Upside: +51.52%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $1.71
Upside: +426.32%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $31.26
Upside: +139.92%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $13.62
Upside: +61.53%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $98.83
Upside: +21.42%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $148.14
Upside: +39.06%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $193.27
Upside: -24.98%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $15.23
Upside: -1.51%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $14.50
Upside: +1,279.31%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $36.76
Upside: -29.27%